Generating iPSCs: translating cell reprogramming science into scalable and robust biomanufacturing strategies.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 25575079.
- Also identified by DOI 10.1016/j.stem.2014.12.013.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Induced pluripotent stem cells (iPSCs) have the potential to transform drug discovery and healthcare in the 21(st) century. However, successful commercialization will require standardized manufacturing platforms. Here we highlight the need to define standardized practices for iPSC generation and processing and discuss current challenges to the robust manufacture of iPSC products.
Medical subject headings
- Cell Culture Techniques
- Cellular Reprogramming
- Induced Pluripotent Stem Cells